Is IGF-1 DES approved as a medicine, and where?

IGF-1 DES is included for catalog coverage, but its regulatory status has not yet been independently verified. The page does not imply approval or safe use.

What is IGF-1 DES studied for?

IGF-1 DES is most often discussed in the context of peptideguide source catalog — verification pending. Being studied for an area does not mean it is proven or approved for it.

Does IGF-1 DES have human clinical trials?

Our review has not yet established whether IGF-1 DES has relevant human evidence. The source record is published without presenting PeptideGuide claims as facts.

Index by category›

Performance & Growth Research

IGF-1 DES

Des(1-3) IGF-1

1 min read · Updated July 27, 2026 · 1 references

Curated by PeptideInfo Wikilast reviewed July 27, 2026how we verify

Explored forPeptideGuide source catalog — verification pending

In brief · TL;DR

Source record — verification pending

IGF-1 DES is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.

Evidence: Catalog coverage only; independent identity, evidence and regulatory review is still pending.

Catalog-coverage record; not an independently verified monograph
PeptideGuide dosing, safety and efficacy claims are not reproduced as facts
Noindexed until identity and primary sources pass editorial review

↓ Read the full referenced entry below

IGF-1 DES is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.

Contents4

Section 1 of 4Why this page exists

Why this page exists

IGF-1 DES appears in the live PeptideGuide compound database and was absent from PeptideInfo when the coverage audit began. This page closes that catalog gap without converting a secondary-source claim into medical fact.

Catalog-coverage record; not an independently verified monograph

PeptideGuide dosing, safety and efficacy claims are not reproduced as facts. Noindexed until identity and primary sources pass editorial review.

Section 2 of 4Source identity

Source identity

The imported source identifies this record as IGF-1 DES and expands the name as Des(1-3) IGF-1. PeptideGuide places it in its Performance category and applies the source label standard. Those labels describe the imported record, not PeptideInfo’s independent conclusion.

Source record ID: igf-1-des. Snapshot row: 103.

Section 3 of 4What is withheld

What is withheld

The source snapshot contains the following claim fields: mechanism, dosing, safety rating, half-life, citation leads, regulatory/development label, molecular-weight claim. Their values remain in quarantine and are intentionally not repeated here as dosing, safety, mechanism, efficacy or approval guidance.

Section 4 of 4Editorial next step

Editorial next step

Editorial lane: independent-source-verification. The page can leave review-pending status only after exact identity is resolved and relevant regulator records or primary literature replace the external source claims.

References1

References

1.
PeptideGuide compound database — discovery source only source

Frequently asked questions4

Frequently asked questions

What is IGF-1 DES?: IGF-1 DES is included for complete PeptideGuide catalog coverage. Identity, evidence, regulatory status and safety claims are awaiting independent verification.
Is IGF-1 DES approved as a medicine, and where?: IGF-1 DES is included for catalog coverage, but its regulatory status has not yet been independently verified. The page does not imply approval or safe use.
What is IGF-1 DES studied for?: IGF-1 DES is most often discussed in the context of peptideguide source catalog — verification pending. Being studied for an area does not mean it is proven or approved for it.
Does IGF-1 DES have human clinical trials?: Our review has not yet established whether IGF-1 DES has relevant human evidence. The source record is published without presenting PeptideGuide claims as facts.

Educational disclaimer. This article summarizes published research for informational purposes and is not medical advice. IGF-1 DES is a catalog record whose identity, evidence and regulatory status have not yet been independently verified; the page does not claim approval, safety or suitability for use. Consult a qualified healthcare professional before making health decisions.